Coronavirus Disease 2019 (COVID-19) Impact on Publicly Traded Bio/Pharma Companies

The coronavirus (COVID-19) company impact report analyses how the pandemic has impact the top 20 Mega Cap Bio/Pharma Companies revenue, future revenue, and market capitalization.

Scope

This 34-page PowerPoint based report gives an important expert analysis on how COVID-19 has affected, and will continue to affect, the top 20 Mega Cap Bio/Pharma Companies. Findings are based on the industry’s most comprehensive platform the Pharma Intelligence Center, including Deals, News, Drugs, Sales, Clinical Trials database and recent analysis.

Reasons to buy

An overview of how the top 20 Mega Cap Bio/Pharma Companies have been affected, and will continue to be affected, by the COVID-19 pandemic.

Companies mentioned

Johnson & Johnson

F. Hoffmann-La Roche Ltd

Novartis AG

Merck & Co Inc

Pfizer Inc

Bristol-Myers Squibb Co

Amgen Inc

AbbVie Inc

AstraZeneca Plc

Eli Lilly and Co

Sanofi

GlaxoSmithKline Plc

Novo Nordisk AS

CSL Ltd

Gilead Sciences Inc

Bayer AG

Allergan Plc

Vertex Pharmaceuticals Inc

Biogen Inc

Regeneron Pharmaceuticals Inc

Table of Contents

1. Market Cap Change for Bio/Pharma Companies in Q1 2020

– Market Cap for Bio/Pharma Companies With and Without a COVID-19 Drug

over Q1 2020

– Q1 2020 Change in Market Cap by Company Market Cap Size

2. Market Cap for Top 20 Bio/Pharma Companies: Q1 2020 vs. 2019

– Market Cap Change for Top 20 Bio/Pharma: Q1 2020 vs. 2019

– Market Cap Change Q1 2020: Bayer AG

– Market Cap Change Q1 2020: Gilead Sciences

Market Cap Change Q1 2020: Regeneron Pharmaceuticals

– Q1 2020 Market Cap Change for Top 20 Bio/Pharma: With and Without a

COVID-19 Drug

– Market Cap Growth: Q1 2020 vs. 2019 Biggest Movers

– Market Cap Change Q1 2020: AbbVie Inc

3. Drug Sales for Top 20 Bio/Pharma Companies vs. Market Cap

– Global Total Drug Sales for Q1 2020 vs. Market Cap

4. Drug Sales for Top 20 Bio/Pharma Companies Q1 2020 vs. Q4 2019

– Global Total Drug Sales Q1 2020 vs. Q4 2019

5. Drug Sales for Top 20 Bio/Pharma Companies vs. Archived Forecasts

– Q1 2020 Actual Sales vs. Archived Global Analyst Consensus Sales Forecast

for Top-Selling Drugs

– Total Q1 2020 Actual Sales vs. Total Archived Global Analyst Consensus Sales

Forecast

Key Findings

Appendix

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports